{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:35:58Z","timestamp":1793730958380,"version":"4.6.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970757"],"award-info":[{"award-number":["81970757"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670714"],"award-info":[{"award-number":["81670714"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Program of Clinical Science","award":["WBYZ2011-873"],"award-info":[{"award-number":["WBYZ2011-873"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2016-I2M-3-003"],"award-info":[{"award-number":["2016-I2M-3-003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00198-020-05649-w","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T23:12:37Z","timestamp":1601421157000},"page":"737-745","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Iron deficiency plays essential roles in the trigger, treatment, and prognosis of autosomal dominant hypophosphatemic rickets"],"prefix":"10.1007","volume":"32","author":[{"given":"C.","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7768-5536","authenticated-orcid":false,"given":"W.","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,30]]},"reference":[{"issue":"2","key":"5649_CR1","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1210\/jcem.82.2.3765","volume":"82","author":"MJ Econs","year":"1997","unstructured":"Econs MJ, McEnery PT (1997) Autosomal dominant hypophosphatemic rickets\/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder. J Clin Endocrinol Metab 82(2):674\u2013681. https:\/\/doi.org\/10.1210\/jcem.82.2.3765","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"5649_CR2","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1359\/jbmr.070107","volume":"22","author":"EA Imel","year":"2007","unstructured":"Imel EA, Hui SL, Econs MJ (2007) FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets. J Bone Miner Res 22(4):520\u2013526. https:\/\/doi.org\/10.1359\/jbmr.070107","journal-title":"J Bone Miner Res"},{"issue":"3","key":"5649_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/81664","volume":"26","author":"A Consortium","year":"2000","unstructured":"Consortium A (2000) Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 26(3):345\u2013348. https:\/\/doi.org\/10.1038\/81664","journal-title":"Nat Genet"},{"issue":"1","key":"5649_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00774-009-0111-5","volume":"28","author":"M Gribaa","year":"2010","unstructured":"Gribaa M, Younes M, Bouyacoub Y, Korbaa W, Ben Charfeddine I, Touzi M, Adala L, Mamay O, Bergaoui N, Saad A (2010) An autosomal dominant hypophosphatemic rickets phenotype in a Tunisian family caused by a new FGF23 missense mutation. J Bone Miner Metab 28(1):111\u2013115. https:\/\/doi.org\/10.1007\/s00774-009-0111-5","journal-title":"J Bone Miner Metab"},{"issue":"11","key":"5649_CR5","doi-asserted-by":"publisher","first-page":"9843","DOI":"10.1074\/jbc.M210490200","volume":"278","author":"XY Bai","year":"2003","unstructured":"Bai XY, Miao D, Goltzman D, Karaplis AC (2003) The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency. J Biol Chem 278(11):9843\u20139849. https:\/\/doi.org\/10.1074\/jbc.M210490200","journal-title":"J Biol Chem"},{"issue":"6","key":"5649_CR6","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1046\/j.1523-1755.2001.00064.x","volume":"60","author":"KE White","year":"2001","unstructured":"White KE, Carn G, Lorenz-Depiereux B, Benet-Pages A, Strom TM, Econs MJ (2001) Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int 60(6):2079\u20132086. https:\/\/doi.org\/10.1046\/j.1523-1755.2001.00064.x","journal-title":"Kidney Int"},{"issue":"3","key":"5649_CR7","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19(3):429\u2013435. https:\/\/doi.org\/10.1359\/JBMR.0301264","journal-title":"J Bone Miner Res"},{"issue":"27","key":"5649_CR8","doi-asserted-by":"publisher","first-page":"18370","DOI":"10.1074\/jbc.M602469200","volume":"281","author":"K Kato","year":"2006","unstructured":"Kato K, Jeanneau C, Tarp MA et al (2006) Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation. J Biol Chem 281(27):18370\u201318377. https:\/\/doi.org\/10.1074\/jbc.M602469200","journal-title":"J Biol Chem"},{"issue":"15","key":"5649_CR9","doi-asserted-by":"publisher","first-page":"5520","DOI":"10.1073\/pnas.1402218111","volume":"111","author":"VS Tagliabracci","year":"2014","unstructured":"Tagliabracci VS, Engel JL, Wiley SE et al (2014) Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis. Proc Natl Acad Sci U S A 111(15):5520\u20135525. https:\/\/doi.org\/10.1073\/pnas.1402218111","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"5649_CR10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/jbmr.2049","volume":"29","author":"EL Clinkenbeard","year":"2014","unstructured":"Clinkenbeard EL, Farrow EG, Summers LJ, Cass TA, Roberts JL, Bayt CA, Lahm T, Albrecht M, Allen MR, Peacock M, White KE (2014) Neonatal iron deficiency causes abnormal phosphate metabolism by elevating FGF23 in normal and ADHR mice. J Bone Miner Res 29(2):361\u2013369. https:\/\/doi.org\/10.1002\/jbmr.2049","journal-title":"J Bone Miner Res"},{"issue":"46","key":"5649_CR11","doi-asserted-by":"publisher","first-page":"E1146","DOI":"10.1073\/pnas.1110905108","volume":"108","author":"EG Farrow","year":"2011","unstructured":"Farrow EG, Yu X, Summers LJ et al (2011) Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice. Proc Natl Acad Sci U S A 108(46):E1146\u2013E1155. https:\/\/doi.org\/10.1073\/pnas.1110905108","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"5649_CR12","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.1210\/jc.2011-1239","volume":"96","author":"EA Imel","year":"2011","unstructured":"Imel EA, Peacock M, Gray AK, Padgett LR, Hui SL, Econs MJ (2011) Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans. J Clin Endocrinol Metab 96(11):3541\u20133549. https:\/\/doi.org\/10.1210\/jc.2011-1239","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"5649_CR13","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s00223-019-00597-y","volume":"105","author":"C Liu","year":"2019","unstructured":"Liu C, Zhao Z, Wang O, Li M, Xing X, Hsieh E, Fukumoto S, Jiang Y, Xia W (2019) Earlier onset in autosomal dominant hypophosphatemic rickets of R179 than R176 mutations in fibroblast growth factor 23: report of 20 Chinese cases and review of the literature. Calcif Tissue Int 105(5):476\u2013486. https:\/\/doi.org\/10.1007\/s00223-019-00597-y","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"5649_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1620\/tjem.213.1","volume":"213","author":"K Furuyama","year":"2007","unstructured":"Furuyama K, Kaneko K, Vargas PD (2007) Heme as a magnificent molecule with multiple missions: heme determines its own fate and governs cellular homeostasis. Tohoku J Exp Med 213(1):1\u201316. https:\/\/doi.org\/10.1620\/tjem.213.1","journal-title":"Tohoku J Exp Med"},{"issue":"3","key":"5649_CR15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.bbagen.2011.10.013","volume":"1820","author":"K Gkouvatsos","year":"2012","unstructured":"Gkouvatsos K, Papanikolaou G, Pantopoulos K (2012) Regulation of iron transport and the role of transferrin. Biochim Biophys Acta 1820(3):188\u2013202. https:\/\/doi.org\/10.1016\/j.bbagen.2011.10.013","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"5649_CR16","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1182\/blood-2013-06-508325","volume":"123","author":"NJ Kassebaum","year":"2014","unstructured":"Kassebaum NJ, Jasrasaria R, Naghavi M et al (2014) A systematic analysis of global anemia burden from 1990 to 2010. Blood 123(5):615\u2013624. https:\/\/doi.org\/10.1182\/blood-2013-06-508325","journal-title":"Blood"},{"issue":"6","key":"5649_CR17","doi-asserted-by":"publisher","first-page":"F1369","DOI":"10.1152\/ajprenal.00281.2016","volume":"311","author":"MR Hanudel","year":"2016","unstructured":"Hanudel MR, Chua K, Rappaport M et al (2016) Effects of dietary iron intake and chronic kidney disease on fibroblast growth factor 23 metabolism in wild-type and hepcidin knockout mice. Am J Physiol Renal Physiol 311(6):F1369\u2013F1377. https:\/\/doi.org\/10.1152\/ajprenal.00281.2016","journal-title":"Am J Physiol Renal Physiol"},{"issue":"7","key":"5649_CR18","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nrneph.2015.82","volume":"11","author":"MJ Koury","year":"2015","unstructured":"Koury MJ, Haase VH (2015) Anaemia in kidney disease: harnessing hypoxia responses for therapy. Nat Rev Nephrol 11(7):394\u2013410. https:\/\/doi.org\/10.1038\/nrneph.2015.82","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"5649_CR19","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1093\/ndt\/gfy189","volume":"34","author":"MR Hanudel","year":"2019","unstructured":"Hanudel MR, Eisenga MF, Rappaport M et al (2019) Effects of erythropoietin on fibroblast growth factor 23 in mice and humans. Nephrol Dial Transplant 34(12):2057\u20132065. https:\/\/doi.org\/10.1093\/ndt\/gfy189","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"5649_CR20","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.kint.2017.11.018","volume":"93","author":"L Toro","year":"2018","unstructured":"Toro L, Barrientos V, Leon P et al (2018) Erythropoietin induces bone marrow and plasma fibroblast growth factor 23 during acute kidney injury. Kidney Int 93(5):1131\u20131141. https:\/\/doi.org\/10.1016\/j.kint.2017.11.018","journal-title":"Kidney Int"},{"issue":"14","key":"5649_CR21","doi-asserted-by":"publisher","first-page":"9795","DOI":"10.1074\/jbc.M113.527150","volume":"289","author":"LM Coe","year":"2014","unstructured":"Coe LM, Madathil SV, Casu C, Lanske B, Rivella S, Sitara D (2014) FGF-23 is a negative regulator of prenatal and postnatal erythropoiesis. J Biol Chem 289(14):9795\u20139810. https:\/\/doi.org\/10.1074\/jbc.M113.527150","journal-title":"J Biol Chem"},{"issue":"7","key":"5649_CR22","doi-asserted-by":"publisher","first-page":"3752","DOI":"10.1096\/fj.201700667R","volume":"32","author":"R Agoro","year":"2018","unstructured":"Agoro R, Montagna A, Goetz R, Aligbe O, Singh G, Coe LM, Mohammadi M, Rivella S, Sitara D (2018) Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia. FASEB J 32(7):3752\u20133764. https:\/\/doi.org\/10.1096\/fj.201700667R","journal-title":"FASEB J"},{"issue":"1","key":"5649_CR23","doi-asserted-by":"publisher","first-page":"7294","DOI":"10.1038\/s41598-018-25439-z","volume":"8","author":"KH Nam","year":"2018","unstructured":"Nam KH, Kim H, An SY et al (2018) Circulating fibroblast growth factor-23 levels are associated with an increased risk of anemia development in patients with nondialysis chronic kidney disease. Sci Rep 8(1):7294. https:\/\/doi.org\/10.1038\/s41598-018-25439-z","journal-title":"Sci Rep"},{"issue":"9","key":"5649_CR24","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1093\/ndt\/gfw331","volume":"32","author":"J Rossaint","year":"2017","unstructured":"Rossaint J, Unruh M, Zarbock A (2017) Fibroblast growth factor 23 actions in inflammation: a key factor in CKD outcomes. Nephrol Dial Transplant 32(9):1448\u20131453. https:\/\/doi.org\/10.1093\/ndt\/gfw331","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"5649_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.semnephrol.2016.02.001","volume":"36","author":"T Ganz","year":"2016","unstructured":"Ganz T, Nemeth E (2016) Iron balance and the role of hepcidin in chronic kidney disease. Semin Nephrol 36(2):87\u201393. https:\/\/doi.org\/10.1016\/j.semnephrol.2016.02.001","journal-title":"Semin Nephrol"},{"issue":"9","key":"5649_CR26","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1210\/jc.2015-2391","volume":"100","author":"K Kapelari","year":"2015","unstructured":"Kapelari K, Kohle J, Kotzot D, Hogler W (2015) Iron supplementation associated with loss of phenotype in autosomal dominant hypophosphatemic rickets. J Clin Endocrinol Metab 100(9):3388\u20133392. https:\/\/doi.org\/10.1210\/jc.2015-2391","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"5649_CR27","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/jbmr.3878","volume":"35","author":"EA Imel","year":"2020","unstructured":"Imel EA, Liu Z, Coffman M, Acton D, Mehta R, Econs MJ (2020) Oral iron replacement normalizes fibroblast growth factor 23 in iron-deficient patients with autosomal dominant hypophosphatemic rickets. J Bone Miner Res 35(2):231\u2013238. https:\/\/doi.org\/10.1002\/jbmr.3878","journal-title":"J Bone Miner Res"},{"key":"5649_CR28","doi-asserted-by":"publisher","first-page":"115137","DOI":"10.1016\/j.bone.2019.115137","volume":"131","author":"LP Menon","year":"2020","unstructured":"Menon LP, Weinstein RS (2020) Iron replacement ameliorates hypophosphatemia in autosomal dominant hypophosphatemic rickets: a review of the role of iron. Bone 131:115137. https:\/\/doi.org\/10.1016\/j.bone.2019.115137","journal-title":"Bone"},{"key":"5649_CR29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.bone.2013.12.001","volume":"60","author":"EA Imel","year":"2014","unstructured":"Imel EA, Gray AK, Padgett LR, Econs MJ (2014) Iron and fibroblast growth factor 23 in X-linked hypophosphatemia. Bone. 60:87\u201392. https:\/\/doi.org\/10.1016\/j.bone.2013.12.001","journal-title":"Bone."},{"issue":"2","key":"5649_CR30","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/jbmr.3941","volume":"35","author":"W Hogler","year":"2020","unstructured":"Hogler W, Kapelari K (2020) Oral iron for prevention and treatment of rickets and osteomalacia in autosomal dominant hypophosphatemia. J Bone Miner Res 35(2):226\u2013230. https:\/\/doi.org\/10.1002\/jbmr.3941","journal-title":"J Bone Miner Res"},{"key":"5649_CR31","unstructured":"WHO (2011) Serum ferritin concentrations for the assessment of iron status and iron deficiency in populations. Vitamin and Mineral Nutrition Information System. Geneva, World Health Organization. (WHO:NMH:NHD:MNM:11.2)"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-020-05649-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-020-05649-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-020-05649-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:44:19Z","timestamp":1632962659000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-020-05649-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,30]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["5649"],"URL":"https:\/\/doi.org\/10.1007\/s00198-020-05649-w","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,30]]},"assertion":[{"value":"4 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Our study was approved by the Institutional Review Boards of Peking Union Medical College Hospital (PUMCH). Written informed consent was obtained from all subjects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}